Brussels, May 26, 2010 (ots/PRNewswire) - The first major survey of European Multiple Sclerosis (MS) nurses revealed that nearly one in three nurses (31%) reported that standards of MS care are not adequately maintained in their country. The results of this survey will be presented for the first time on Friday ...
Basel, Switzerland (ots/PRNewswire) - - New Analysis of Data From landmark 'Valsartan Heart Failure Trial' Adds to Growing Evidence That Plasma Renin Activity (PRA) is Linked to Cardiovascular Outcomes (1-3) - PRA is a Measure of the Activity of the Renin Angiotensin System (RAS) - The Only High Blood ...
Basel, Switzerland (ots/PRNewswire) - - Not For US Media - Set to Become First Medicine in EU to Treat Patients Aged Four and Older Suffering From Life-Long Cryopyrin-Associated Periodic Syndrome (CAPS)(1) - Ilaris Targets Interleukin-1 Beta (IL-1 Beta), a key Driver of Inflammation(1,2,3) - Studies ...
Basel, Switzerland (ots/PRNewswire) - - Not for US Media - New Ilaris Data in The New England Journal of Medicine Show Rapid Sustained Efficacy in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)(1) - CAPS is a Debilitating Genetic Disorder With Potentially Fatal Complications and Limited ...
Basel, Switzerland (ots/PRNewswire) - - Novartis Vaccines on track to be the first to manufacture new cell culture-derived influenza vaccines in the United States - New site to support pandemic preparedness - First submission of a cell culture-derived influenza vaccine in the European ...